HK1216506A1 - 含硒組合物及其治療和預防與線粒體功能障礙有關的疾病或病症的應用 - Google Patents

含硒組合物及其治療和預防與線粒體功能障礙有關的疾病或病症的應用

Info

Publication number
HK1216506A1
HK1216506A1 HK16104529.4A HK16104529A HK1216506A1 HK 1216506 A1 HK1216506 A1 HK 1216506A1 HK 16104529 A HK16104529 A HK 16104529A HK 1216506 A1 HK1216506 A1 HK 1216506A1
Authority
HK
Hong Kong
Prior art keywords
selenium
disease
prevention
compositions
treatment
Prior art date
Application number
HK16104529.4A
Other languages
English (en)
Inventor
Ronan Power
Casey Egan
Alexandros Yiannikouris
Zi-Jian Lan
Rijin Xiao
Lewis Collen Jackson
Stefan Kwiatkowski
Original Assignee
Alltech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alltech Inc filed Critical Alltech Inc
Publication of HK1216506A1 publication Critical patent/HK1216506A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
HK16104529.4A 2013-03-15 2016-04-20 含硒組合物及其治療和預防與線粒體功能障礙有關的疾病或病症的應用 HK1216506A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361788133P 2013-03-15 2013-03-15
PCT/US2014/029328 WO2014144776A1 (en) 2013-03-15 2014-03-14 Compositions comprising selenium and use of same for the treatment and prevention of disease or conditions associated with mitochondrial dysfunction

Publications (1)

Publication Number Publication Date
HK1216506A1 true HK1216506A1 (zh) 2016-11-18

Family

ID=51537786

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16104529.4A HK1216506A1 (zh) 2013-03-15 2016-04-20 含硒組合物及其治療和預防與線粒體功能障礙有關的疾病或病症的應用

Country Status (15)

Country Link
US (1) US9833486B2 (zh)
EP (1) EP2968404A4 (zh)
JP (1) JP6313418B2 (zh)
KR (1) KR102245702B1 (zh)
CN (3) CN114533753A (zh)
AU (1) AU2014228785B2 (zh)
BR (1) BR112015022514A2 (zh)
CA (1) CA2903845C (zh)
CL (1) CL2015002677A1 (zh)
HK (1) HK1216506A1 (zh)
MX (1) MX359626B (zh)
RU (1) RU2663127C2 (zh)
SG (2) SG10202101918RA (zh)
WO (1) WO2014144776A1 (zh)
ZA (1) ZA201506759B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014152795A2 (en) 2013-03-14 2014-09-25 Schentag Jerome J Cholestosome vesicles for incorporation of molecules into chylomicrons
KR102466389B1 (ko) * 2014-03-14 2022-11-11 올텍 법인회사 셀레노유기 화합물의 조성물 및 이의 사용 방법
CA2981138A1 (en) 2015-03-27 2016-10-06 The Research Foundation For The State University Of New York Methods and materials for reducing amyloid beta levels within a mammal
WO2017048252A1 (en) * 2015-09-15 2017-03-23 Alltech, Inc. Compositions of selenoorganic compounds and methods of use thereof
EP3429373A4 (en) * 2016-03-14 2019-07-17 Mitogenetics, LLC MATERIALS AND METHOD FOR TREATING HYPOXIC CONDITIONS
BR112019022918A2 (pt) 2017-05-19 2020-05-26 Alltech, Inc. Agentes farmacêuticos, composições e métodos relativos aos mesmos
CN108283711A (zh) * 2018-05-06 2018-07-17 冷立娟 一种治疗酒精性心肌病的中药冲剂及其制备方法
CN109820933A (zh) * 2019-02-27 2019-05-31 北京曲佳科技有限公司 减肥片及其制备方法
CN111493325A (zh) * 2020-05-07 2020-08-07 恩施德源健康科技发展有限公司 植物硒肽在制备改善肥胖及代谢综合征组合物中的应用
CN112129864B (zh) * 2020-09-24 2022-04-01 江南大学 一种富硒植物干粉中硒形态测定的方法
KR102328808B1 (ko) * 2020-12-02 2021-11-22 동의대학교 산학협력단 맥주효모를 이용한 근감소증 예방 및 개선용 조성물
CN114053298A (zh) * 2021-11-19 2022-02-18 华中农业大学 一种用于抑制心肌肥大的药物及模型的构建方法
CN114235989A (zh) * 2021-11-27 2022-03-25 山东省烟台市农业科学研究院 一种测定福美甲胂含量的高效液相色谱法
CN114031650B (zh) * 2021-11-29 2023-05-02 上海交通大学 壳寡糖硒配位化合物及其制备方法和应用
CN114931569B (zh) * 2022-06-22 2023-05-16 中国农业科学院油料作物研究所 甲基硒代半胱氨酸在制备提高雄性生殖能力的产品中的应用
CN116333302A (zh) * 2023-03-31 2023-06-27 中南大学 一种稳定持久抗氧化纳米点及其在二型糖尿病中的应用
CN116421618B (zh) * 2023-06-15 2023-09-29 暨南大学 Se@NADH的制备方法及其在脊髓损伤治疗中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5896024A (ja) * 1981-10-16 1983-06-07 リチヤ−ド・エフ・ストツケル 白金毒解毒剤
WO2004107881A1 (en) * 2003-06-04 2004-12-16 Serfontein, Willem, Jacob Nutritional compositions and use thereof
PL214402B1 (pl) * 2003-08-11 2013-07-31 Tomasz Byrski Zastosowanie selenu albo jego zwiazku do otrzymywania srodka do obnizania odziedziczonego ryzyka zachorowania na raka piersi lub jajnika
US20070026090A1 (en) * 2003-09-05 2007-02-01 Oren Tirosh Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
CN102764279B (zh) * 2005-10-14 2015-04-01 全面技术公司 改变细胞功能的方法和组合物
US8871715B2 (en) * 2005-10-14 2014-10-28 Alltech, Inc. Use of selenium compounds, especially selenium yeasts for altering cognitive function
US20100247679A1 (en) * 2006-04-24 2010-09-30 Alltech, Inc. Methods and compositions for altering cell function
WO2008144543A2 (en) * 2007-05-18 2008-11-27 Alltech, Inc. Compositions and methods for establishing and/or maintaining pregnancy
NZ583025A (en) * 2007-07-31 2012-06-29 Univ Texas Micro-rnas that control myosin expression and myofiber identity
EP2192905A4 (en) * 2007-08-29 2010-11-10 Adam Lubin METHOD FOR SELECTIVE THERAPY OF DISEASE
ES2378595T3 (es) * 2007-10-16 2012-04-16 Actigenomics S.A. Composición destinada a la regulación del metabolismo de los lípidos
CN101579355B (zh) * 2009-05-27 2010-12-08 徐建兴 一种维护线粒体功能的营养组合物及其应用
WO2011047434A1 (en) * 2009-10-22 2011-04-28 Propanc Pty Ltd A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
US8883498B2 (en) * 2010-04-22 2014-11-11 Kyoto University Method for inducing differentiation of pluripotent stem cells into skeletal muscle or skeletal muscle progenitor cells
KR20120048205A (ko) * 2010-11-05 2012-05-15 한국식품연구원 메틸셀레노시스테인을 유효성분으로 함유하는 비만 및 지질 관련 대사성 질환의 예방 및 치료용 조성물
KR102100091B1 (ko) 2011-04-13 2020-04-14 아지노모토 가부시키가이샤 영양 조성물

Also Published As

Publication number Publication date
US9833486B2 (en) 2017-12-05
ZA201506759B (en) 2017-03-29
NZ711842A (en) 2021-04-30
SG10202101918RA (en) 2021-03-30
CA2903845A1 (en) 2014-09-18
CN105377271A (zh) 2016-03-02
CA2903845C (en) 2022-08-23
CN114984038A (zh) 2022-09-02
EP2968404A1 (en) 2016-01-20
RU2663127C2 (ru) 2018-08-01
EP2968404A4 (en) 2017-01-04
MX2015013275A (es) 2015-12-11
JP2016516058A (ja) 2016-06-02
KR20150132374A (ko) 2015-11-25
CL2015002677A1 (es) 2016-12-09
KR102245702B1 (ko) 2021-04-28
BR112015022514A2 (pt) 2017-07-18
RU2015139742A (ru) 2017-04-21
SG11201507061XA (en) 2015-10-29
CN114533753A (zh) 2022-05-27
MX359626B (es) 2018-10-01
US20160113977A1 (en) 2016-04-28
JP6313418B2 (ja) 2018-04-18
WO2014144776A1 (en) 2014-09-18
AU2014228785A1 (en) 2015-09-24
AU2014228785B2 (en) 2018-01-25

Similar Documents

Publication Publication Date Title
HK1216506A1 (zh) 含硒組合物及其治療和預防與線粒體功能障礙有關的疾病或病症的應用
HK1250910A1 (zh) 疫苗和pd-1途徑抑制劑的組合
IL256624B (en) Pharmaceutical compounds and preparations thereof for the treatment of inflammatory disorders
IL242483B (en) Preparations containing omomyc and their use for cancer treatment
HK1221874A1 (zh) 包含魚油和果汁的組合物用於癌症的治療和/或後治療的用途
HUE046924T2 (hu) Módszerek és készítmények Barth szindróma megelõzésében vagy kezelésében történõ alkalmazásra
IL244621A (en) Preparations for the treatment of hypertension and / or fibrosis
IL244622A0 (en) Preparations for the treatment of hypertension and/or fibrosis
HK1220374A1 (zh) 用於治療碳氧血紅蛋白血症的組合物和方法
HK1225994A1 (zh) 用於治療過敏性病症的組合物
EP2948219A4 (en) TARGETING THE STEROIDOGENIC PATH TO TREAT AND / OR PREVENT ALLERGIC DISEASES
EP2964750A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND / OR PREVENTING TYPE-1 DIABETES
PT2862576T (pt) Microrganismos e composições que os compreendem para utilização no tratamento ou prevenção de mastite
IL259383A (en) A compound for use in the prevention and treatment of neurodegenerative diseases
IL245998A0 (en) Pharmaceutical preparations and a method for the treatment of metastatic cancer and its prevention
PL3041459T3 (pl) Kompozycje przydatne w zapobieganiu lub leczeniu raka skóry
GB201316698D0 (en) Use of tri-substituted glycerol compounds for prevention and treatment of allo-immune disorders